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Methods: Animal models: experimental OA was induced in male Wistar
rats by intra-articular injection of 3mg mono-iodoacetate (MIA) into the
right knee, the left knee served as a control and was injected with
saline (biochemical model, n = 4); A second OA model was used to
verify model speciﬁc macrophage activity, we used the surgical anterior
ligament transection model (ACLT, n = 2). As a positive control, we used a
rheumatoid arthritis (RA) mouse model in which RA was induced into the
right knee by injection of methylated bovine serum albumin (mBSA) after
immunisation (n = 2). In this RA model, activated macrophages are known
to be involved abundantly. 24 hours prior to imaging animals we injected
with radioactive labeled folic acid (111In-DOTA-FA). Images of the animals
were obtained using a dedicated small animal multipinhole SPECT/CT
camera (nano-SPECT/CT, Bioscan inc.). Images were obtained at 3, 27
and 52 days after OA induction.
Results: All three models (RA, ACLT, MIA) showed increased uptake of
the 111In-DOTA-FA, not only in the synovial region of the knee, but also
in the plopliteal and inguinal lymph node regions at 15 27 and 52 days.
However, the uptake of activity was less in the experimental OA models
than in the RA model. The MIA model showed a higher activity rate in the
lymph node regions than was seen in the ACLT-model, in which activated
macrophages seemed to play a more prominent role in the synovium.
(a−d) MPH-SPECT/CT images of a RA-mouse (a) and OA rats (b,c =MIA,
d =ACLT) in frontal plane 3D (a,b) and sagittal plane 2D (c,d). Note the
excess activation of macrophages in the lymphoid tissue in the RA mouse
and less in the MIA rat (red arrows) and the activation in the synovial
tissue (white arrow). The SPECT image is represented in color, the micro-
CT image is in grey.
Conclusions: Macrophage activation in experimental OA could clearly
be monitored by SPECT/CT in combination with a folate tracer. As
expected we found increased activation around the knee area, probably
the synovium, though the amount of activity of macrophages in the
lymphoid system up to the inguinal nodes in experimental OA was not
as expected. This shows that macrophages play not only a local role but
are also involved in a more systemic response to the affected knee. This
response is known in RA, in which macrophages have a (auto-)antigen
presenting role in the lymph-nodes. Though, such a role for OA is not
known. By investigating a surgical as well as a biochemical OA-model
it becomes less likely that there is a direct response of macrophages to
the speciﬁc models, as lymph-node activation was high in both models
till the end of the experiment (7.5 wks). To conclude, in-vivo visualization
of activated macrophages in OA provides more insight in OA etiology,
enables to monitor OA intervention strategies and provides a new imaging
biomarker.
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Purpose: Matrix metalloproteases (MMPs) are thought to be important
factors that mediate cartilage loss in osteoarthritis (OA). Il-1 is a strong
inducer of chondrocyte MMP expression however, a role for Il-1 in OA has
never been clearly demonstrated; therefore other factors may play a roll
in regulating MMP expression and cartilage remodeling. Polymorphisms
identiﬁed in genes from the wnt/b-catenin pathway have been associated
with OA and recently, we found that wnt1-inducible secreted protein-1
(WISP1) was expressed at high levels during experimental OA. The aim of
the present study was to examine WISP1 expression in human OA tissue
and to determine the potential of WISP1 to cause cartilage degradation
independently of Il-1.
Methods: Expression of WISP1, both in human OA synovium and
cartilage was determined by Q-PCR and by immunohistochemistry. To
study the effect of WISP1 on cells we stimulated macrophages and
chondrocytes with recombinant WISP1and assayed the effect on the
induction of cartilage degrading enzymes. An adenoviral vector for WISP1
overexpression was generated, and injected in the murine knee joint of
either control mice or Il-1−/− mice. Subsequently, markers for cartilage
degradation were determined.
Results: WISP1 expression in human tissue was 3 times higher in OA
synovium and over 2 times higher in cartilage, compared to control tissue.
In cartilage of OA patients there was clear expression of WISP1 in
chondrocytes and also located pericellularly in the adjacent extracellular
matrix. WISP1 was not detected in control (post-mortem) cartilage. Stimu-
lation of macrophages with WISP1 for 24 hours resulted in the induction of
MMP-3, MMP-9 and MMP-13, 8-, 5- and 3-fold respectively. Remarkably,
no Il-1 was induced by WISP1. In chondrocytes and ﬁbroblasts, only
MMP-3 was signiﬁcantly induced. Synovial overexpression of WISP1
following WISP1-expressing adenovirus injection into murine knee joints
resulted in strong induction of MMP3, MMP-9, MMP-13, ADAMTS4 and
ADAMTS5 in the synovium (12-, 8-, 2-, 10- and 2-fold), and of MMP-3,
MMP-13 and ADAMTS4 in the cartilage (100-, 12, and 3-fold). Neo-
epitope markers for enzymatic cartilage damage, VDIPEN (MMPs) and
NITEGE (aggrecanases) were signiﬁcantly induced in knee joints, 4 days
after WISP1 overexpression. Control virus did not induce any markers
for cartilage degradation. Interestingly, cartilage damage and expression
of catabolic enzymes were identical in Il-1−/− and wild type mice after
WISP1 overexpression, indicating that WISP1 induces cartilage damage
independently of Il-1.
Conclusions:WISP1 is expressed in human OA synovium and cartilage,
and levels are higher compared to controls. WISP1 is a potent inducer
of several MMPs and overexpression causes cartilage degradation. This
effect on cartilage damage is independent of Il-1. We have identiﬁed a
novel mechanism that may contribute to cartilage loss in OA that works
independently of Il-1.
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Purpose: Chondroitin sulfate (CS) is a natural glycosaminoglycan, cur-
rently employed in osteoarthritis, with a therapeutic effect that has been
partially attributed to a potential antiinﬂammatory action on joint cells. We
have previously reported that CS was capable to reduce the markers of
vascular and systemic inﬂammation in rabbits with a combined model of
aterosclerosis and chronic arthritis (British J Pharmacol, 2008). In this
work, our aim was to explore the effect of the administration of CS on
the sinovial injury and on markers of synovial inﬂammation in rabbits with
this combined model and in synovial cells in culture.
Methods: Chronic arthritis was induced by repeated intraarticular in-
jections of ovalbumin in previously immunized rabbits. Atherosclerosis
was simultaneously induced in these rabbits by maintaining them on a
hyperlipidemic diet after producing a femoral de-endothelization. A group
of these rabbits were treated
prophylactically with CS (100mg/kg/day). At sacriﬁce, pheripheral blood
mononuclear cells (PBMC) and synovial membranes were isolated and
stored for expression studies. A piece of synovial membrane was embed-
ded in parafﬁn for histological examination. In order to study the possible
mechanism of action of CS, we also employed human synovial ﬁbroblast
in culture stimulated with Il-1b in the presence or absence of CS (2mM).
Results: In the PBMC from rabbits with the combined model, CS inhib-
ited the expression of monocyte chemoattractant protein (MCP)-1 and
cyclooxigenase (COX)-2 (determined by quantitative PCR and western
blot) and the activation of the NFkB (studied by mobility shift assay). In
the synovial membrane, CS signiﬁcantly diminished the gene expression
and the protein synthesis of COX-2 and MCP-1 and the histopathological
synovitis score (Krenn scale) in comparison to untreated rabbits. In
fact, in the synovial membrane CS partially prevented the intimal layer
proliferation and the inﬂammatory cell inﬁltration observed in the non-
treated animals. Moreover, in synovial cells in culture, CS presence was
able to inhibit the NFkB activation induced by Il-1b.
